Skip to content
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Neurology

The Why and How: Identifying Your Stroke Subtype

At a Glance

Doctors use the TOAST system to identify the likely cause of an ischemic stroke. Heart monitoring and echocardiograms can reveal heart-related clots, while artery imaging can show plaque or narrowing; the subtype guides treatment and steps to prevent another stroke.

When you experience an ischemic stroke, your medical team isn’t just treating the symptoms; they are acting as detectives to find the “why.” To do this, they use a standard framework called the TOAST classification, which stands for Trial of Org 10172 in Acute Stroke Treatment [1]. This system helps categorize the cause of your stroke into one of five main groups, ensuring your treatment is tailored to your specific needs [2][3].

The Five Subtypes of Stroke

Understanding these categories explains why you may be undergoing a battery of tests, from heart monitors to ultrasounds.

  • Large-Artery Atherosclerosis: This occurs when fatty deposits called plaque build up in the major arteries leading to the brain, such as the carotid arteries in the neck [4]. If a piece of plaque breaks off or a clot forms on its surface, it can block blood flow [5]. Doctors use carotid ultrasounds or CT angiograms to look for this narrowing [6].
  • Cardioembolism: In this case, a blood clot forms in the heart and travels (or embolizes) to the brain [7]. This is often caused by an irregular heartbeat called atrial fibrillation [8]. This is why your team uses EKGs, telemetry (heart monitoring), and echocardiograms (ultrasounds of the heart) to check for rhythm issues or structural heart problems [9].
  • Small-Vessel (Lacunar) Disease: This involves the very tiny arteries deep inside the brain. These vessels can become damaged over time, usually due to long-term high blood pressure [10]. These strokes are often small and are called lacunar infarcts [11].
  • Other Determined Etiology: This category is for strokes with less common but identified causes, such as a tear in an artery wall (dissection), blood clotting disorders, or inflammation of the blood vessels (vasculitis) [12][13].
  • Undetermined Etiology (Cryptogenic): Despite extensive testing, about 30% to 50% of strokes do not have a clear, single cause found initially [14][15]. This may happen because there are multiple possible causes, or because the source was temporary and difficult to catch [1].

The Ischemic Cascade

When blood flow is blocked, your brain cells experience a rapid series of events called the ischemic cascade [16].

  1. Energy Failure: Without oxygen and glucose, cells lose the energy they need to maintain their electrical balance [17].
  2. Cellular Damage: This leads to a buildup of calcium and other chemicals that become toxic to the cell, eventually causing it to die [18].
  3. Oxidative Stress: As cells struggle, they produce harmful molecules called reactive oxygen species. These act like “rust,” damaging the cell’s internal machinery [19].

The primary goal of emergency stroke care is reperfusion—restoring blood flow as quickly as possible to save threatened tissue [20]. Re-establishing blood flow is lifesaving and the benefits greatly outweigh the risks, but doctors carefully monitor you afterward because the sudden influx of oxygen can sometimes trigger temporary inflammation [21][22][23]. Your medical team monitors you closely in the days following a stroke to manage these complex biological reactions [24].

Why Finding the Cause is Vital

Identifying your specific subtype helps doctors tailor your prevention plan [25]. For example, if the cause is cardioembolism from atrial fibrillation, you may need a blood thinner (anticoagulant)—though your doctor will decide the exact timing to start it based on the size of your stroke and your bleeding risk [6][26]. If it is large-artery atherosclerosis, you may need antiplatelet therapy or even surgery to clear the artery [25].

Importantly, even if your stroke cause remains “undetermined” at first, prevention starts immediately. General risk reduction—managing blood pressure, cholesterol, diabetes, and lifestyle—begins while the investigation continues.

Common questions in this guide

What is the TOAST classification for ischemic stroke?
TOAST is a system doctors use to group an ischemic stroke by its likely cause. The five categories are large-artery atherosclerosis, cardioembolism, small-vessel disease, another identified cause, and an undetermined or cryptogenic cause.
What tests help doctors find the cause of an ischemic stroke?
Doctors may use a carotid ultrasound or CT angiography to look for narrowed arteries. EKGs, continuous heart monitoring, and an echocardiogram can look for atrial fibrillation or heart problems that may allow a clot to reach the brain.
What does a cryptogenic or undetermined stroke mean?
It means testing has not found one clear cause for the stroke at that time. There may be more than one possible cause, or the source may have been temporary and difficult to detect, so additional monitoring may be recommended.
How does the stroke subtype affect my treatment?
Treatment depends on the likely source and your bleeding risk. A stroke linked to atrial fibrillation may call for an anticoagulant, while large-artery disease may be treated with antiplatelet medicine and sometimes surgery; your doctor determines the medication and timing.
What is a small-vessel or lacunar stroke?
It is an ischemic stroke involving a tiny artery deep inside the brain. These vessels often become damaged after long-term high blood pressure, and the resulting small stroke is called a lacunar infarct.
Why is rapid reperfusion important after an ischemic stroke?
Blocked blood flow deprives brain cells of oxygen and glucose, triggering a damaging chain of events. Reperfusion restores blood flow and can save threatened brain tissue, but the medical team monitors you afterward for inflammation and other reactions.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which TOAST subtype best describes my stroke, and how does that change the medications I need?
  2. 2.If my stroke is currently 'undetermined,' what additional tests or monitoring (like a heart monitor) do I need?
  3. 3.What did my carotid ultrasound or CT scan show about the health of the arteries in my neck?
  4. 4.Does my imaging show signs of 'small-vessel disease,' and what does that mean for my risk of future strokes?
  5. 5.Was an echocardiogram performed, and did it find any issues with my heart valves or rhythm that could cause clots?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (26)
  1. 1

    Assessment of the Predictive Validity of Etiologic Stroke Classification.

    Arsava EM, Helenius J, Avery R, et al.

    JAMA neurology 2017; (74(4)):419-426 doi:10.1001/jamaneurol.2016.5815.

    PMID: 28241214
  2. 2

    Causes of Acute Stroke: A Patterned Approach.

    Knight-Greenfield A, Nario JJQ, Gupta A

    Radiologic clinics of North America 2019; (57(6)):1093-1108 doi:10.1016/j.rcl.2019.07.007.

    PMID: 31582037
  3. 3

    A comparative analysis of TOAST and ASCOD criteria in etiologic subtyping of acute ischemic stroke at a tertiary hospital in Tanzania.

    Mohammed M, Mabelele MM, Mbithe H, et al.

    Frontiers in stroke 2025; (4()):1598711 doi:10.3389/fstro.2025.1598711.

    PMID: 41541880
  4. 4

    Etiologic Subtypes of Watershed Infarcts.

    Sorgun MH, Rzayev S, Yilmaz V, Isıkay CT

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2015; (24(11)):2478-83.

    PMID: 26375794
  5. 5

    Cerebral border zone infarctions: An etiologic study.

    Hashemilar M, Tohidi P, Forghani N, et al.

    Current journal of neurology 2022; (21(1)):1-6 doi:10.18502/cjn.v21i1.9353.

    PMID: 38011470
  6. 6

    Diagnostic Impact of Intracranial Vessel Wall MRI in 205 Patients with Ischemic Stroke or TIA.

    Schaafsma JD, Rawal S, Coutinho JM, et al.

    AJNR. American journal of neuroradiology 2019; (40(10)):1701-1706 doi:10.3174/ajnr.A6202.

    PMID: 31488500
  7. 7

    Application of TOAST criteria, comorbidities and outcomes in patients with ischemic stroke: multicenter collaboration in the Dominican Republic.

    Then R, Muñoz M, Ramos C, et al.

    Frontiers in stroke 2026; (5()):1877826 doi:10.3389/fstro.2026.1877826.

    PMID: 42438573
  8. 8

    Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance.

    Fonseca AC, Marto JP, Pimenta D, et al.

    Neurology 2020; (94(1)):e107-e113 doi:10.1212/WNL.0000000000008698.

    PMID: 31792090
  9. 9

    Patients With Undetermined Stroke Have Increased Atrial Fibrosis: A Cardiac Magnetic Resonance Imaging Study.

    Fonseca AC, Alves P, Inácio N, et al.

    Stroke 2018; (49(3)):734-737 doi:10.1161/STROKEAHA.117.019641.

    PMID: 29371431
  10. 10

    Lacunar Infarcts, Depression, and Anxiety Symptoms One Year after Stroke.

    Arba F, Ali M, Quinn TJ, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2016; (25(4)):831-4.

    PMID: 26778600
  11. 11

    The role of hypertension and diabetes mellitus on the etiology of middle cerebral artery disease.

    Zhang C, Li Z, Liu L, et al.

    Brain and behavior 2022; (12(4)):e2521 doi:10.1002/brb3.2521.

    PMID: 35307987
  12. 12

    Thirty-day recurrence after ischemic stroke or TIA.

    Khanevski AN, Bjerkreim AT, Novotny V, et al.

    Brain and behavior 2018; (8(10)):e01108 doi:10.1002/brb3.1108.

    PMID: 30222913
  13. 13

    Short-Term and Long-Term Risk of Recurrent Vascular Event by Cause After Ischemic Stroke in Young Adults.

    Verburgt E, Hilkens NA, Ekker MS, et al.

    JAMA network open 2024; (7(2)):e240054 doi:10.1001/jamanetworkopen.2024.0054.

    PMID: 38376841
  14. 14

    Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study.

    Li L, Yiin GS, Geraghty OC, et al.

    The Lancet. Neurology 2015; (14(9)):903-913 doi:10.1016/S1474-4422(15)00132-5.

    PMID: 26227434
  15. 15

    Joinville stroke biobank: study protocol and first year's results.

    Ferreira LE, França PHC, Nagel V, et al.

    Arquivos de neuro-psiquiatria 2017; (75(12)):881-889 doi:10.1590/0004-282X20170157.

    PMID: 29236892
  16. 16

    Drug Design for Cerebral Ischemia: A Molecular Perspective Review.

    Kahvecioglu D

    CNS & neurological disorders drug targets 2026; (25(6)):446-479 doi:10.2174/0118715273407230250916154803.

    PMID: 41088994
  17. 17

    Dodging blood brain barrier with "nano" warriors: Novel strategy against ischemic stroke.

    Parvez S, Kaushik M, Ali M, et al.

    Theranostics 2022; (12(2)):689-719 doi:10.7150/thno.64806.

    PMID: 34976208
  18. 18

    The mitochondria as a potential therapeutic target in cerebral I/R injury.

    Fang S, Huang W, Qu X, Chai W

    Frontiers in neuroscience 2024; (18()):1500647 doi:10.3389/fnins.2024.1500647.

    PMID: 39844858
  19. 19

    Sometimes less is more: inhibitory infrared light during early reperfusion calms hyperactive mitochondria and suppresses reperfusion injury.

    Morse PT, Wan J, Bell J, et al.

    Biochemical Society transactions 2022; (50(5)):1377-1388 doi:10.1042/BST20220446.

    PMID: 36066188
  20. 20

    The effects of hyperbaric oxygen therapy on the brain with middle cerebral artery occlusion.

    Thiankhaw K, Chattipakorn N, Chattipakorn SC

    Journal of cellular physiology 2021; (236(3)):1677-1694 doi:10.1002/jcp.29955.

    PMID: 32692455
  21. 21

    Dynamic mechanisms and targeted interventions in cerebral ischemia-reperfusion injury: pathological cascade from ischemia to reperfusion and promising therapeutic strategies.

    Meng X, Zheng Z, Yang L, et al.

    Frontiers in neuroscience 2025; (19()):1649533 doi:10.3389/fnins.2025.1649533.

    PMID: 40900923
  22. 22

    Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy.

    Ma Y, Chen Z, He Q, et al.

    Pharmacological research 2022; (185()):106482 doi:10.1016/j.phrs.2022.106482.

    PMID: 36195305
  23. 23

    Damage to the blood‑brain barrier and activation of neuroinflammation by focal cerebral ischemia under hyperglycemic condition.

    Guo Y, Dong L, Gong A, et al.

    International journal of molecular medicine 2021; (48(1)).

    PMID: 34080644
  24. 24

    Early Blood-Brain Barrier Disruption in Ischemic Stroke Initiates Multifocally Around Capillaries/Venules.

    Hoffmann A, Dege T, Kunze R, et al.

    Stroke 2018; (49(6)):1479-1487 doi:10.1161/STROKEAHA.118.020927.

    PMID: 29760276
  25. 25

    Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar.

    Diener HC, Hankey GJ

    Journal of the American College of Cardiology 2020; (75(15)):1804-1818 doi:10.1016/j.jacc.2019.12.072.

    PMID: 32299593
  26. 26

    High Resolution Magnetic Resonance Vessel Wall Imaging: A Valuable Addition to Stroke Work-Up.

    Adwane G, Tran A, Seners P, et al.

    European journal of neurology 2026; (33(3)):e70492 doi:10.1111/ene.70492.

    PMID: 41789821

This page is for informational purposes only and does not constitute medical advice. Your stroke team should interpret your test results and recommend treatment based on your specific situation.

Get notified when new evidence is published on cerebral infarction.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.